127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal episode artwork

EPISODE · Mar 13, 2024 · 48 MIN

127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal

from Let's Combinate - Drugs + Devices · host Subhi Saadeh

On this episode I was joined by Naveen Aggarwal founder of Creative Analytic Solutions and host of "Let's talk risk". In this episode, Naveen walks through the big changes to risk management with the QMSR, and risk beyond safety. The episode covers the confusion surrounding the mandatory nature of risk management in particular and we spend the second half of the episode talk about risk acceptability charts, risk & quality policy, explaining vs. justifying risk based decision making with regards to the traffic light charts that most companies use for risk acceptance. Episode Chapters: 02:00 Interpreting the QMSR and Its Implications 05:56 Impact of QMSR on Risk Management 08:34 Risk Management in Practice 12:09 Insights from FDA Inspections and Warning Letters 23:30 The Importance of Process-Based Approach 24:57 Deep Dive into Risk Policy and Risk Acceptability 26:05 Understanding the Framework of 14971 26:42 The Role of Quality Policy in Risk Management 27:32 Risk Control 29:47 Risk Acceptability in Risk Policy 30:59 Understanding Risk Matrix 32:16 Risk Control and Quality Policy 41:00 Understanding Risk Acceptability Charts Naveen Agarwal PhD is an Engineer by training with nearly 20 years of professional experience in Product Development, Quality Systems and Data Analytics. As a result, he's developed a very broad and deep expertise in all of the core functions involved in the entire lifecycle of medical products. Naveen joins us from Creative Analytics Solutions where his mission is Helping Medical Companies Build Safe Products. Naveen is a PhD Polymer scientist turned QM consultant and expert.

Episode metadata supplied by the publisher feed · Published Mar 13, 2024

Embed this episode

NOW PLAYING

127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal

0:00 48:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let's Combinate - Drugs + Devices?

This episode is 48 minutes long.

When was this Let's Combinate - Drugs + Devices episode published?

This episode was published on March 13, 2024.

Can I download this Let's Combinate - Drugs + Devices episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!